Treatment Management of Ischemic Stroke
Ischemic Attack 1-A
Transient
Early aspirin (160-325 mg)
1-A
Acute Ischemic Stroke
O N S E T
≤ 3 h 3-4.5 h > 4.5 h
1-A 2-C
1-B
Proximal occlusion Ineligible for IV r-tPA
≤ 6 h Restricted mobility
Acute Primary Intracerebral Hemorrhage
Cerebral Venous Sinus Thrombosis
2-C Anticoagulation Secondary Prevention Ischemic Stroke or TIA
No Atrial Fibrillation
1-A
release dipyridamole (25 mg/200 mg bid)
aspirin/extended
Clopidogrel (75 mg daily) or
Alternate cilostazol (100 mg bid)
Fibrillation 2-B
Atrial
Dabigatran* 150 mg bid or warfarin
Intracerebral Hemorrhage 2-C
No antithrombotic therapy
Alternate
Aspirin (75-100 mg) daily and
clopidogrel (75 mg daily)
Aspirin (75-100 mg) daily or
IV r-tPA No IV r-tPA 2-C 2-B IA r-tPA
Prophylactic LMWH or
IPCD
